Envveno Medical earnings were -$22.0M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest NVNO earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$4.5M, down 32.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NVNO reported annual earnings of -$21.8M, with -7.2% growth.
What were Envveno Medical's earnings last quarter?
On NVNO's earnings call on Invalid Date, Envveno Medical (NASDAQ: NVNO) reported Q3 2025 earnings per share (EPS) of -$0.23, up 34.29% year over year. Total NVNO earnings for the quarter were -$4.54 million. In the same quarter last year, Envveno Medical's earnings per share (EPS) was -$0.35.
As of the last Envveno Medical earnings report, Envveno Medical is currently losing money. Envveno Medical's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$21.97 million, a 3.42% increase year over year.
What was NVNO's earnings growth in the past year?
As of Envveno Medical's earnings date in Invalid Date, Envveno Medical's earnings has grown year over year. NVNO earnings in the past year totalled -$21.97 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.